Jelonek Karol, Pietrowska Monika, Ros Malgorzata, Zagdanski Adam, Suchwalko Agnieszka, Polanska Joanna, Marczyk Michal, Rutkowski Tomasz, Skladowski Krzysztof, Clench Malcolm R, Widlak Piotr
Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-100 Gliwice, Poland.
Institute of Mathematics and Computer Science, Wroclaw University of Technology, Janiszewskiego 14a, 50-370 Wroclaw, Poland.
Int J Mol Sci. 2014 Apr 17;15(4):6609-24. doi: 10.3390/ijms15046609.
Cancer radiotherapy (RT) induces response of the whole patient's body that could be detected at the blood level. We aimed to identify changes induced in serum lipidome during RT and characterize their association with doses and volumes of irradiated tissue. Sixty-six patients treated with conformal RT because of head and neck cancer were enrolled in the study. Blood samples were collected before, during and about one month after the end of RT. Lipid extracts were analyzed using MALDI-oa-ToF mass spectrometry in positive ionization mode. The major changes were observed when pre-treatment and within-treatment samples were compared. Levels of several identified phosphatidylcholines, including (PC34), (PC36) and (PC38) variants, and lysophosphatidylcholines, including (LPC16) and (LPC18) variants, were first significantly decreased and then increased in post-treatment samples. Intensities of changes were correlated with doses of radiation received by patients. Of note, such correlations were more frequent when low-to-medium doses of radiation delivered during conformal RT to large volumes of normal tissues were analyzed. Additionally, some radiation-induced changes in serum lipidome were associated with toxicity of the treatment. Obtained results indicated the involvement of choline-related signaling and potential biological importance of exposure to clinically low/medium doses of radiation in patient's body response to radiation.
癌症放射治疗(RT)会引发患者全身的反应,这种反应可在血液水平上检测到。我们旨在确定放疗期间血清脂质组中发生的变化,并描述其与受照射组织的剂量和体积之间的关联。66例因头颈癌接受适形放疗的患者被纳入本研究。在放疗开始前、放疗期间以及放疗结束后约一个月采集血样。脂质提取物采用基质辅助激光解吸电离-正交加速飞行时间质谱在正离子模式下进行分析。比较治疗前和治疗期间的样本时观察到了主要变化。几种已鉴定的磷脂酰胆碱水平,包括(PC34)、(PC36)和(PC38)变体,以及溶血磷脂酰胆碱水平,包括(LPC16)和(LPC18)变体,在治疗后样本中先显著降低,然后升高。变化强度与患者接受的辐射剂量相关。值得注意的是,在分析适形放疗期间向大量正常组织输送的低至中等剂量辐射时,这种相关性更为常见。此外,血清脂质组中一些辐射诱导的变化与治疗毒性有关。获得的结果表明胆碱相关信号传导的参与以及临床低/中等剂量辐射暴露在患者对辐射的身体反应中的潜在生物学重要性。